What is Rigel Pharmaceuticals Inc. (New)'s Market Cap?

Rigel Pharmaceuticals Inc. (New)'s Market Cap is $882.1M, based on as-reported figures from SEC (XBRL) filings.

What is Rigel Pharmaceuticals Inc. (New)'s Enterprise Value?

Rigel Pharmaceuticals Inc. (New)'s Enterprise Value is $826.7M, based on as-reported figures from SEC (XBRL) filings.

What is Rigel Pharmaceuticals Inc. (New)'s Trailing P/E?

Rigel Pharmaceuticals Inc. (New)'s Trailing P/E is 2.7×, based on as-reported figures from SEC (XBRL) filings.

What is Rigel Pharmaceuticals Inc. (New)'s Price / Sales?

Rigel Pharmaceuticals Inc. (New)'s Price / Sales is 3.2×, based on as-reported figures from SEC (XBRL) filings.

What is Rigel Pharmaceuticals Inc. (New)'s EV / Revenue?

Rigel Pharmaceuticals Inc. (New)'s EV / Revenue is 3.0×, based on as-reported figures from SEC (XBRL) filings.

What is Rigel Pharmaceuticals Inc. (New)'s EV / EBITDA?

Rigel Pharmaceuticals Inc. (New)'s EV / EBITDA is 9.2×, based on as-reported figures from SEC (XBRL) filings.

What is Rigel Pharmaceuticals Inc. (New)'s Revenue (TTM)?

Rigel Pharmaceuticals Inc. (New)'s Revenue (TTM) is $276.8M, based on as-reported figures from SEC (XBRL) filings.

What is Rigel Pharmaceuticals Inc. (New)'s Net Income (TTM)?

Rigel Pharmaceuticals Inc. (New)'s Net Income (TTM) is $321.9M, based on as-reported figures from SEC (XBRL) filings.

What is Rigel Pharmaceuticals Inc. (New)'s EBITDA?

Rigel Pharmaceuticals Inc. (New)'s EBITDA is $89.7M, based on as-reported figures from SEC (XBRL) filings.

What is Rigel Pharmaceuticals Inc. (New)'s Diluted EPS (TTM)?

Rigel Pharmaceuticals Inc. (New)'s Diluted EPS (TTM) is 17.23, based on as-reported figures from SEC (XBRL) filings.

Rigel Pharmaceuticals Inc. (New) (RIGL) Financial Statements

Rigel Pharmaceuticals Inc. (New)

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SD33Z0

XNAS · usd

47.22▼ 0.15 (-0.32%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close47.37

Day's Range46.78 – 47.88

52-Week Range24.82 – 52.24

Volume122.8K

Avg Volume272.5K

Share Statistics

Shares Outstanding

Employees174

ExchangeXNAS

Listed2000-11-29

Share count as of July 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Rigel Pharmaceuticals Inc. (New) (RIGL)

What is Rigel Pharmaceuticals Inc. (New)'s Market Cap?: Rigel Pharmaceuticals Inc. (New)'s Market Cap is $882.1M, based on as-reported figures from SEC (XBRL) filings.
What is Rigel Pharmaceuticals Inc. (New)'s Enterprise Value?: Rigel Pharmaceuticals Inc. (New)'s Enterprise Value is $826.7M, based on as-reported figures from SEC (XBRL) filings.
What is Rigel Pharmaceuticals Inc. (New)'s Trailing P/E?: Rigel Pharmaceuticals Inc. (New)'s Trailing P/E is 2.7×, based on as-reported figures from SEC (XBRL) filings.
What is Rigel Pharmaceuticals Inc. (New)'s Price / Sales?: Rigel Pharmaceuticals Inc. (New)'s Price / Sales is 3.2×, based on as-reported figures from SEC (XBRL) filings.
What is Rigel Pharmaceuticals Inc. (New)'s EV / Revenue?: Rigel Pharmaceuticals Inc. (New)'s EV / Revenue is 3.0×, based on as-reported figures from SEC (XBRL) filings.
What is Rigel Pharmaceuticals Inc. (New)'s EV / EBITDA?: Rigel Pharmaceuticals Inc. (New)'s EV / EBITDA is 9.2×, based on as-reported figures from SEC (XBRL) filings.
What is Rigel Pharmaceuticals Inc. (New)'s Revenue (TTM)?: Rigel Pharmaceuticals Inc. (New)'s Revenue (TTM) is $276.8M, based on as-reported figures from SEC (XBRL) filings.
What is Rigel Pharmaceuticals Inc. (New)'s Net Income (TTM)?: Rigel Pharmaceuticals Inc. (New)'s Net Income (TTM) is $321.9M, based on as-reported figures from SEC (XBRL) filings.
What is Rigel Pharmaceuticals Inc. (New)'s EBITDA?: Rigel Pharmaceuticals Inc. (New)'s EBITDA is $89.7M, based on as-reported figures from SEC (XBRL) filings.
What is Rigel Pharmaceuticals Inc. (New)'s Diluted EPS (TTM)?: Rigel Pharmaceuticals Inc. (New)'s Diluted EPS (TTM) is 17.23, based on as-reported figures from SEC (XBRL) filings.